Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Johnson and Johnson
McKinsey
Baxter
Moodys

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

BROMPHENIRAMINE MALEATE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Brompheniramine Maleate, and what generic alternatives are available?

Brompheniramine Maleate is a drug marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Acella, Mayne Pharma Inc, Paddock Llc, Taro, and Vintage Pharms. and is included in twenty-one NDAs.

The generic ingredient in BROMPHENIRAMINE MALEATE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

Summary for BROMPHENIRAMINE MALEATE
Drug patent expirations by year for BROMPHENIRAMINE MALEATE
Recent Clinical Trials for BROMPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ache Laboratorios Farmaceuticos S.A.Phase 3
Wyeth is now a wholly owned subsidiary of PfizerN/A

See all BROMPHENIRAMINE MALEATE clinical trials

Medical Subject Heading (MeSH) Categories for BROMPHENIRAMINE MALEATE
Synonyms for BROMPHENIRAMINE MALEATE
( inverted question mark)-Brompheniramine maleate
(-)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(?)-Brompheniramine maleate
(+-)-2-p-Bromo-alpha-2-(dimethylamino)ethylbenzylpyridine maleate (1:1)
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+/-)-Brompheniramine maleate
(+/-)-Brompheniramine maleate salt
(A+/-)-Brompheniramine maleate
(S)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (Z)-maleate (1:1)
(y)-Brompheniramine maleate
1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate
2- p-Bromo-a-2-(dimethylamino)ethylbenzylpyridine maleate
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (Z)-butenedioate (1:1)
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (Z)-but-2-enedioic acid
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid
3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
32865-01-3
8055-73-0
86-22-6 (Parent)
980-71-2
AB2000679
AC-1311
AC1NQXZ5
AKOS015855858
Allent
AN-15069
AS-14101
B 2390
BC214875
BCP0726000240
BCP9000453
BCPP000315
Bioompheniramine hydrogen maleate
Bromopheniramine maleate
Brompheniramine (maleate)
Brompheniramine d-form maleate
Brompheniramine fumarate
Brompheniramine hydrogen maleate
Brompheniramine maleate (USAN)
Brompheniramine maleate [USP]
Brompheniramine Maleate 1.0 mg/ml in Methanol (as free base)
Brompheniramine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Brompheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
Brompheniramine maleate, United States Pharmacopeia (USP) Reference Standard
brompheniramine; maleic acid
CCG-39068
CHEBI:3184
CHEMBL1200961
CS-2595
d-Brompheniramine maleate
D00663
Dimetane
Dimetane (TN)
Dimetane Extentabs
Dimetane-ten
Dimetapp Allergy
Dimotane
Drauxin
Drixoral Syrup
DTXSID2052657
Ebalin
EINECS 213-562-9
EINECS 219-236-2
EU-0100201
Gammistin
HMS1569O12
HMS1922O16
HMS2093O07
HMS2096O12
HMS2230I21
HMS2234D14
HMS3260J03
HMS3713O12
HY-B0480
Ilvin
l-Brompheniramine maleate
Lodrane
LP00201
LS-130306
LS-130307
LS-130309
LS-130310
MLS000028423
MLS001148196
MolPort-003-666-520
Nagemid
NCGC00093676-01
NCGC00093676-02
NCGC00093676-03
NCGC00093676-04
NCGC00093676-05
NCGC00260886-01
NSC-758652
NSC758652
Opera_ID_399
Parabromdylamine maleate
Pharmakon1600-01503985
Prestwick_913
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1)
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (-)-
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (S)-
Rolabromophen
s2585
SCHEMBL41913
SMR000058417
SMR000653459
SPECTRUM1503985
Spentane
SR-01000003057
SR-01000003057-2
SR-01000003057-4
SR-01000003057-5
SR-01000003057-8
SW197031-3
Tox21_500201
Veltane
W-100095

US Patents and Regulatory Information for BROMPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms BROMPHENIRAMINE MALEATE brompheniramine maleate ELIXIR;ORAL 086936-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mayne Pharma Inc BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 207676-001 Dec 4, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Barr BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 084468-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
AstraZeneca
McKesson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.